Literature DB >> 7567187

Juvenile dermatomyositis. Pathophysiology and disease expression.

L M Pachman1.   

Abstract

In summary, the child who develops the symptoms of the specific rash, proximal muscle weakness, or fatigue should seek medical care promptly. With the advances in physical and medical therapy, many of the consequences of the disease can now be ameliorated. Data suggest that JDMS and PM may each have a different pathophysiology, but more evidence is needed. The next few years will be exciting as there is a national effort by an increased number of investigators to determine the epidemiologic and genetic factors that influence JDMS disease susceptibility and severity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567187     DOI: 10.1016/s0031-3955(16)40054-4

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  10 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  Management of rheumatic diseases in children.

Authors:  B H Athreya
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

3.  Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl.

Authors:  P K Paspalaki; E P Mihailidou; M Bitsori; D Tsagkaraki; E Mantzouranis
Journal:  BMC Musculoskelet Disord       Date:  2001-11-20       Impact factor: 2.362

Review 4.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 5.  Juvenile dermatomyositis: recognition and treatment.

Authors:  Ann M Reed; Maricarmen Lopez
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis-old method, new discovery.

Authors:  Alice Y K Chan; Edmund Li
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 2.980

7.  Juvenile dermatomyositis associated with subclinical hypothyroidism due to auto-immune thyroiditis.

Authors:  Tohshin Go; Izuru Mitsuyoshi
Journal:  Eur J Pediatr       Date:  2002-04-16       Impact factor: 3.183

8.  Dermatomyositis and Polymyositis.

Authors:  Hannah R. Briemberg; Anthony A. Amato
Journal:  Curr Treat Options Neurol       Date:  2003-09       Impact factor: 3.598

Review 9.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

10.  Aggressive immunosuppressive treatment of Susac's syndrome in an adolescent: using treatment of dermatomyositis as a model.

Authors:  Robert M Rennebohm; Martin Lubow; Jerome Rusin; Lisa Martin; Deborah M Grzybowski; John O Susac
Journal:  Pediatr Rheumatol Online J       Date:  2008-01-29       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.